Keywords: yoshitomi, rises, organ, rejection, drug, pharmaceutical, boosted

Yoshitomi rises on organ rejection drug

Article | 21 December 1999

Print This

Yoshitomi Pharmaceutical was boosted recently on news that the companyplans to start domestic studies of FTY-720, a drug to prevent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in